Patents Assigned to Epivax, Inc.
  • Modified H7 hemagglutinin glycoprotein of the Influenza A/Shanghai/2/2013 H7 sequence
    Patent number: 10286063
    Abstract: The present invention is directed to a sequence modification of the H7 hemagglutinin glycoprotein of the Influenza A/Shanghai/2/2013 H7 sequence together with vaccines derived therefrom. In addition, the invention further comprises method for improving the efficacy of vaccine antigens by modifying T cell epitopes.
    Type: Grant
    Filed: May 2, 2016
    Date of Patent: May 14, 2019
    Assignee: EPIVAX, INC.
    Inventors: Anne S De Groot, William D Martin
  • METHODS FOR IMPROVING THE EFFICACY OF VACCINE ANTIGENS
    Publication number: 20190105386
    Abstract: The present technology is directed to a sequence modification of the H7 hemagglutinin glycoprotein of the Influenza A/Shanghai/2/2013 H7 sequence together with vaccines derived therefrom. In addition, the invention further comprises method for improving the efficacy of vaccine antigens by modifying T cell epitopes.
    Type: Application
    Filed: November 28, 2018
    Publication date: April 11, 2019
    Applicant: EpiVax, Inc.
    Inventors: Anne S. De Groot, William D. Martin
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 10213496
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: September 17, 2015
    Date of Patent: February 26, 2019
    Assignee: EPIVAX, INC.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20190030144
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: October 16, 2018
    Publication date: January 31, 2019
    Applicant: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20190030143
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: October 16, 2018
    Publication date: January 31, 2019
    Applicant: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20180289787
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: June 22, 2018
    Publication date: October 11, 2018
    Applicant: EpiVax, Inc.
    Inventors: Anne DE GROOT, William MARTIN, Daniel S. RIVERA
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20180289786
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: June 22, 2018
    Publication date: October 11, 2018
    Applicant: EpiVax, Inc.
    Inventors: Anne DE GROOT, William MARTIN, Daniel S. RIVERA
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20180289784
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: June 22, 2018
    Publication date: October 11, 2018
    Applicant: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20180289785
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: June 22, 2018
    Publication date: October 11, 2018
    Applicant: EpiVax, Inc.
    Inventors: Anne DE GROOT, William MARTIN, Daniel S. RIVERA
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20180289788
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: June 22, 2018
    Publication date: October 11, 2018
    Applicant: EpiVax, Inc.
    Inventors: Anne DE GROOT, William MARTIN, Daniel S. RIVERA
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20180289783
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: June 22, 2018
    Publication date: October 11, 2018
    Applicant: EpiVax, Inc.
    Inventors: Anne DE GROOT, William MARTIN, Daniel S. RIVERA
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20180289782
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: June 22, 2018
    Publication date: October 11, 2018
    Applicant: EpiVax, Inc.
    Inventors: Anne DE GROOT, William MARTIN, Daniel S. RIVERA
  • Modified H7 Hemagglutinin Glycoprotein of the Influenza A/Shanghai/2/2013 H7 Sequence
    Publication number: 20180179256
    Abstract: The present invention is directed to a sequence modification of the H7 hemagglutinin glycoprotein of the Influenza A/Shanghai/2/2013 H7 sequence together with vaccines derived therefrom. In addition, the invention further comprises method for improving the efficacy of vaccine antigens by modifying T cell epitopes.
    Type: Application
    Filed: April 15, 2016
    Publication date: June 28, 2018
    Applicants: EpiVax, Inc., National Institute of Infectious Diseases
    Inventors: Anne S De Groot, William D Martin, Yoshimasa Takahashi, Manabu Ato
  • Modified H7 Hemagluttinin Glycoprotein of the Influenza A/Shanghai/2/2013 H7 Sequence
    Publication number: 20180161418
    Abstract: The present invention is directed to a sequence modification of the H7 hemagglutinin glycoprotein of the Influenza A/Shanghai/2/2013 H7 sequence together with vaccines derived therefrom. In addition, the invention further comprises method for improving the efficacy of vaccine antigens by modifying T cell epitopes.
    Type: Application
    Filed: May 2, 2016
    Publication date: June 14, 2018
    Applicant: EpiVax, Inc.
    Inventors: Anne S De Groot, William D Martin
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 7884184
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: January 29, 2008
    Date of Patent: February 8, 2011
    Assignee: Epivax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera